Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer (IPG659)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 14 August 2019
Endocuff Vision for assisting visualisation during colonoscopy (MTG45)Product type:GuidanceProgramme:Medical technologies guidancePublished date: 7 June 2019
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (TA439)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 25 September 2017Published date: 29 March 2017
Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30)Product type:GuidanceProgramme:Diagnostics guidancePublished date: 26 July 2017
Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 July 2017Published date: 23 June 2015
Endoscopic full thickness removal of non-lifting colonic polyps (IPG580)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 24 May 2017
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)Product type:GuidanceProgramme:Diagnostics guidancePublished date: 10 May 2017
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) (TA240)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 29 March 2017Published date: 14 December 2011
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)Product type:GuidanceProgramme:Diagnostics guidancePublished date: 22 February 2017
Trifluridine–tipiracil for previously treated metastatic colorectal cancer (TA405)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 24 August 2016
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer (IPG532)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 23 September 2015
Preoperative high dose rate brachytherapy for rectal cancer (IPG531)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 26 August 2015
Transanal total mesorectal excision of the rectum (IPG514)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 27 March 2015
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal) (TA334)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 25 February 2015
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)Product type:GuidanceProgramme:Diagnostics guidancePublished date: 10 December 2014
Colorectal cancer: diagnosis and management (CG131)Product type:GuidanceProgramme:Clinical guidelineLast updated: 3 December 2014Published date: 1 November 2011
Combined endoscopic and laparoscopic removal of colonic polyps (IPG503)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 26 September 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy (TA307)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 25 March 2014
Selective internal radiation therapy for non-resectable colorectal metastases in the liver (IPG401)Product type:GuidanceProgramme:Interventional procedures guidanceLast updated: 1 May 2013Published date: 27 July 2011
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (TA242)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 25 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (TA118)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 January 2012Published date: 24 January 2007
Endoscopic radical inguinal lymphadenectomy (IPG398)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 22 June 2011
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas (CG118)Product type:GuidanceProgramme:Clinical guidelinePublished date: 23 March 2011
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer (TA212)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 15 December 2010
Radiofrequency ablation for colorectal liver metastases (IPG327)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 16 December 2009
Laparoscopic surgery for colorectal cancer (TA105)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 23 August 2006
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer (TA100)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 26 April 2006
Computed tomographic colonography (virtual colonoscopy) (IPG129)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 22 June 2005
Improving outcomes in colorectal cancer (CSG5)Product type:GuidanceProgramme:Cancer service guidelinePublished date: 23 June 2004
Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) (IPG56)Product type:GuidanceProgramme:Interventional procedures guidancePublished date: 28 April 2004
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (TA61)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 27 May 2003
Endo-SPONGE for colorectal anastomotic leakage (MIB188)Product type:AdviceProgramme:Medtech innovation briefingPublished date: 5 August 2019
ColonFlag for identifying people at risk of colorectal cancer (MIB142)Product type:AdviceProgramme:Medtech innovation briefingPublished date: 12 April 2018
OSNA for colon cancer staging (MIB77)Product type:AdviceProgramme:Medtech innovation briefingPublished date: 24 August 2016
Suspected cancer (QS124)Product type:Quality standardLast updated: 5 December 2017Published date: 30 June 2016
GatewayC: Improving early detection of cancer through e-learning for primary careProduct type:Shared learningPublished date: 31 January 2019
Overcoming the challenges of implementing the new NICE guidance for suspected cancer: recognition and referralProduct type:Shared learningPublished date: 8 January 2017
Implementing early rectal cancer multidisciplinary teams in secondary careProduct type:Shared learningPublished date: 10 January 2012